Nevro Quick Ratio 2013-2023 | NVRO
Nevro Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2023-12-31 | $0.41B | $0.08B | 4.94 |
2023-09-30 | $0.40B | $0.08B | 5.01 |
2023-06-30 | $0.41B | $0.08B | 5.31 |
2023-03-31 | $0.42B | $0.08B | 5.64 |
2022-12-31 | $0.46B | $0.08B | 5.85 |
2022-09-30 | $0.47B | $0.08B | 5.82 |
2022-06-30 | $0.39B | $0.07B | 5.36 |
2022-03-31 | $0.40B | $0.07B | 5.69 |
2021-12-31 | $0.44B | $0.08B | 5.32 |
2021-09-30 | $0.45B | $0.08B | 5.97 |
2021-06-30 | $0.47B | $0.07B | 6.37 |
2021-03-31 | $0.65B | $0.25B | 2.65 |
2020-12-31 | $0.67B | $0.24B | 2.80 |
2020-09-30 | $0.66B | $0.24B | 2.75 |
2020-06-30 | $0.63B | $0.22B | 2.83 |
2020-03-31 | $0.32B | $0.06B | 5.26 |
2019-12-31 | $0.33B | $0.07B | 4.68 |
2019-09-30 | $0.31B | $0.07B | 4.54 |
2019-06-30 | $0.31B | $0.07B | 4.66 |
2019-03-31 | $0.32B | $0.07B | 4.87 |
2018-12-31 | $0.35B | $0.06B | 5.64 |
2018-09-30 | $0.34B | $0.05B | 6.31 |
2018-06-30 | $0.34B | $0.05B | 6.29 |
2018-03-31 | $0.33B | $0.05B | 6.17 |
2017-12-31 | $0.34B | $0.06B | 5.91 |
2017-09-30 | $0.33B | $0.05B | 6.81 |
2017-06-30 | $0.32B | $0.04B | 8.72 |
2017-03-31 | $0.32B | $0.03B | 9.43 |
2016-12-31 | $0.34B | $0.04B | 7.94 |
2016-09-30 | $0.34B | $0.04B | 9.71 |
2016-06-30 | $0.33B | $0.03B | 10.94 |
2016-03-31 | $0.20B | $0.03B | 7.82 |
2015-12-31 | $0.22B | $0.04B | 6.05 |
2015-09-30 | $0.24B | $0.02B | 10.07 |
2015-06-30 | $0.27B | $0.02B | 16.53 |
2015-03-31 | $0.17B | $0.01B | 12.63 |
2014-12-31 | $0.19B | $0.01B | 17.25 |
2014-09-30 | $0.04B | $0.01B | 4.76 |
2014-06-30 | $0.00B | 0.00 | |
2014-03-31 | $0.00B | 0.00 | |
2013-12-31 | $0.00B | 0.00 | |
2013-09-30 | $0.00B | 0.00 | |
2012-12-31 | $0.04B | $0.01B | 7.49 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.525B | $0.425B |
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $220.921B | 26.90 |
Intuitive Surgical (ISRG) | United States | $141.815B | 88.52 |
Edwards Lifesciences (EW) | United States | $57.273B | 37.91 |
DexCom (DXCM) | United States | $53.772B | 92.37 |
IQVIA Holdings (IQV) | United States | $45.841B | 27.19 |
IDEXX Laboratories (IDXX) | United States | $44.833B | 53.58 |
Alcon (ALC) | Switzerland | $41.065B | 30.28 |
STERIS (STE) | Ireland | $22.285B | 26.38 |
Waters (WAT) | United States | $20.436B | 29.38 |
Hologic (HOLX) | United States | $18.156B | 20.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.065B | 83.36 |
Sysmex ADR (SSMXY) | Japan | $11.407B | 35.78 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.361B | 14.03 |
Teleflex (TFX) | United States | $10.535B | 16.56 |
Penumbra (PEN) | United States | $8.762B | 108.32 |
Masimo (MASI) | United States | $7.645B | 42.87 |
Globus Medical (GMED) | United States | $7.183B | 22.77 |
Glaukos (GKOS) | United States | $4.585B | 0.00 |
Integer Holdings (ITGR) | United States | $3.844B | 24.64 |
LivaNova (LIVN) | United Kingdom | $3.015B | 19.88 |
Elekta AB (EKTAY) | Sweden | $2.904B | 19.92 |
Inari Medical (NARI) | United States | $2.747B | 474.00 |
Integra LifeSciences Holdings (IART) | United States | $2.738B | 11.23 |
PROCEPT BioRobotics (PRCT) | United States | $2.489B | 0.00 |
TransMedics (TMDX) | United States | $2.424B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.388B | 20.19 |
Tandem Diabetes Care (TNDM) | United States | $2.317B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.904B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Veracyte (VCYT) | United States | $1.586B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.997B | 0.00 |
Paragon 28 (FNA) | United States | $0.987B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.01 |
Artivion (AORT) | United States | $0.891B | 103.00 |
Treace Medical Concepts (TMCI) | United States | $0.763B | 0.00 |
OPKO Health (OPK) | United States | $0.746B | 0.00 |
Silk Road Medical (SILK) | United States | $0.733B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.650B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.579B | 19.64 |
IRadimed (IRMD) | United States | $0.549B | 31.89 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.463B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.377B | 12.69 |
CVRx (CVRX) | United States | $0.376B | 0.00 |
NeuroPace (NPCE) | United States | $0.358B | 0.00 |
AxoGen (AXGN) | United States | $0.336B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
Accuray (ARAY) | United States | $0.241B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.229B | 0.00 |
AngioDynamics (ANGO) | United States | $0.227B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
Semler Scientific (SMLR) | United States | $0.201B | 10.81 |
Inogen (INGN) | United States | $0.186B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.181B | 0.00 |
Neuronetics (STIM) | United States | $0.143B | 0.00 |
Delcath Systems (DCTH) | United States | $0.125B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.118B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.076B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.064B | 130.67 |
Vasomedical (VASO) | United States | $0.057B | 4.36 |
InspireMD (NSPR) | Israel | $0.054B | 0.00 |
Autonomix Medical (AMIX) | $0.052B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.043B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.025B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.022B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.015B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.007B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |